Tag: Granules India

Granules’ generic for ADHD secures U.S. FDA tentative nod

cpooldigitalLeave a Comment on Granules’ generic for ADHD secures U.S. FDA tentative nod

[ad_1] The U.S. FDA approval further strengthens the U.S. generics portfolio of the Granules’, says the company’s CMD. File | Photo Credit: Reuters Granules India, through a subsidiary, has received U.S. Food and Drug Administration’s (FDA’s) tentative approval for its generic of attention deficit hyperactivity disorder drug Adzenys-XR-ODT. The product, indicated for the treatment of […]

Continue Reading

Granules Life Sciences secures first U.S. FDA approval

cpooldigitalLeave a Comment on Granules Life Sciences secures first U.S. FDA approval

[ad_1] “We plan on launching the product in the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” Granules India CMD Krishna Prasad Chigurupati said in a release.  | Photo Credit: Photo Courtesy: www.linkedin.com/in/krishna-prasad-chigurupati Generic drugmaker Granules India subsidiary Granules Life […]

Continue Reading